Evidence map›Paper›PMID 29947926›Full record

ArticleCellular and molecular life sciences : CMLS2018

OSBP-related protein-2 (ORP2): a novel Akt effector that controls cellular energy metabolism.

Henriikka Kentala, Annika Koponen, Helena Vihinen, Juho Pirhonen, Gerhard Liebisch, Zoltan Pataj, Annukka Kivelä, Shiqian Li, Leena Karhinen, Eeva Jääskeläinen and 7 more

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Frontiers in genetics · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Henriikka KentalaMinerva Foundation Institute for Medical Research, Biomedicum 2U, Tukholmankatu 8, 00290, Helsinki, Finland.
Annika KoponenMinerva Foundation Institute for Medical Research, Biomedicum 2U, Tukholmankatu 8, 00290, Helsinki, Finland.
Helena VihinenElectron Microscopy Unit, Institute of Biotechnology, University of Helsinki, 00014, Helsinki, Finland.
Juho PirhonenMinerva Foundation Institute for Medical Research, Biomedicum 2U, Tukholmankatu 8, 00290, Helsinki, Finland.
Gerhard LiebischInstitute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053, Regensburg, Germany.
Zoltan PatajInstitute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053, Regensburg, Germany.
Annukka KiveläMinerva Foundation Institute for Medical Research, Biomedicum 2U, Tukholmankatu 8, 00290, Helsinki, Finland.
Shiqian LiMinerva Foundation Institute for Medical Research, Biomedicum 2U, Tukholmankatu 8, 00290, Helsinki, Finland.
Leena KarhinenDepartment of Anatomy, Faculty of Medicine, University of Helsinki, 00014, Helsinki, Finland.
Eeva JääskeläinenMinerva Foundation Institute for Medical Research, Biomedicum 2U, Tukholmankatu 8, 00290, Helsinki, Finland.
Robert AndrewsSystems Immunity Research Institute, Cardiff University, Cardiff, CF14 4XN, UK.
Leena MeriläinenElectron Microscopy Unit, Institute of Biotechnology, University of Helsinki, 00014, Helsinki, Finland.
Silke MatysikInstitute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053, Regensburg, Germany.
Elina IkonenMinerva Foundation Institute for Medical Research, Biomedicum 2U, Tukholmankatu 8, 00290, Helsinki, Finland.
You ZhouMinerva Foundation Institute for Medical Research, Biomedicum 2U, Tukholmankatu 8, 00290, Helsinki, Finland.
Eija JokitaloElectron Microscopy Unit, Institute of Biotechnology, University of Helsinki, 00014, Helsinki, Finland.
Vesa M OlkkonenMinerva Foundation Institute for Medical Research, Biomedicum 2U, Tukholmankatu 8, 00290, Helsinki, Finland. vesa.olkkonen@helsinki.fi.ORCID http://orcid.org/0000-0001-5553-7997
University of Helsinki · FIMinerva Foundation · FIUniversity Hospital Regensburg · DECardiff University · GB

Funding

Academy of Finland 285223Academy of Finland 307415Academy of Finland 312491
6 · The paper itself

Abstract

ORP2 is a ubiquitously expressed OSBP-related protein previously implicated in endoplasmic reticulum (ER)-lipid droplet (LD) contacts, triacylglycerol (TG) metabolism, cholesterol transport, adrenocortical steroidogenesis, and actin-dependent cell dynamics. Here, we characterize the role of ORP2 in carbohydrate and lipid metabolism by employing ORP2-knockout (KO) hepatoma cells (HuH7) generated by CRISPR-Cas9 gene editing. The ORP2-KO and control HuH7 cells were subjected to RNA sequencing, analyses of Akt signaling, carbohydrate and TG metabolism, the extracellular acidification rate, and the lipidome, as well as to transmission electron microscopy. The loss of ORP2 resulted in a marked reduction of active phosphorylated Akt(Ser473) and its target Glycogen synthase kinase 3β(Ser9), consistent with defective Akt signaling. ORP2 was found to form a physical complex with the key controllers of Akt activity, Cdc37, and Hsp90, and to co-localize with Cdc37 and active Akt(Ser473) at lamellipodial plasma membrane regions, in addition to the previously reported ER-LD localization. ORP2-KO reduced glucose uptake, glycogen synthesis, glycolysis, mRNA-encoding glycolytic enzymes, and SREBP-1 target gene expression, and led to defective TG synthesis and storage. ORP2-KO did not reduce but rather increased ER-LD contacts under basal culture conditions and interfered with their expansion upon fatty acid loading. Together with our recently published work (Kentala et al. in FASEB J 32:1281-1295, 2018), this study identifies ORP2 as a new regulatory nexus of Akt signaling, cellular energy metabolism, actin cytoskeletal function, cell migration, and proliferation.

Indexed as

Actin CytoskeletonBiological TransportCell Cycle ProteinsCell LineCell MovementCell ProliferationChaperoninsEnergy MetabolismGene Knockout TechniquesHSP90 Heat-Shock ProteinsHumansLipid MetabolismOrganellesOxysterol Binding ProteinsProto-Oncogene Proteins c-aktReceptors, SteroidCDC37 protein, humanCell Cycle ProteinsChaperoninsHSP90 Heat-Shock ProteinsOSBPL2 protein, humanOxysterol Binding ProteinsProto-Oncogene Proteins c-aktReceptors, SteroidRNA, MessengerAkt signalingCRISPR-Cas9GlycolysisOSBPL2OSBP-related proteinTriacylglycerol

Identifiers

PMID29947926
PMCPMC11105326
OpenAlexW2808705890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.